Clarity Pharmaceuticals Ltd (ASX: CU6)
Australia
· Delayed Price · Currency is AUD
3.900
+0.080 (2.09%)
Jan 21, 2025, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 1.23 billion as of January 17, 2025. Its market cap has increased by 130.21% in one year.
Market Cap
1.23B
Enterprise Value
1.09B
Revenue
11.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.90
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 1.23B, an increase of 218.97%. That is a compound annual growth rate of 40.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jan 20, 2025 | 1.23B | -8.39% |
Dec 31, 2024 | 1.34B | 168.49% |
Dec 29, 2023 | 498.26M | 93.82% |
Dec 30, 2022 | 257.07M | 35.63% |
Dec 31, 2021 | 189.54M | -50.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 133.19B |
Pro Medicus | 25.99B |
Cochlear | 19.84B |
Sonic Healthcare | 13.27B |
Telix Pharmaceuticals | 8.90B |
Ramsay Health Care | 7.83B |
Ansell | 4.94B |
Sigma Healthcare | 4.45B |